| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
| 04/12/2011 | US7923015 Methods for direct visualization of active synapses |
| 04/12/2011 | US7923014 Expression and purification of HIP/PAP and uses therefor |
| 04/12/2011 | US7923013 Glycolipids and analogues thereof as antigens for NKT cells |
| 04/12/2011 | US7923012 Immunizing an animal using polypeptide; amino acid sequences; controlling phosphate, vitamin D metabolism |
| 04/12/2011 | US7923011 Antibodies to lymphotoxin-alpha |
| 04/12/2011 | US7923010 Methods and materials for treating autoimmune diseases and conditions |
| 04/12/2011 | US7923009 Medicinal agent and method for curing prostate diseases |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | US7923001 Compositions and methods for diagnosing and treating urinary tract infections |
| 04/12/2011 | CA2626498C Recombinant chimeric virus |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/07/2011 | WO2011041691A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | WO2011041642A1 Microparticle compositions and methods for treating age-related macular degeneration |
| 04/07/2011 | WO2011041613A2 Combination immunotherapy for the treatment of cancer |
| 04/07/2011 | WO2011041441A1 Endoglin antibodies |
| 04/07/2011 | WO2011041391A1 Influenza hemagglutinin antibodies, compositions, and related methods |
| 04/07/2011 | WO2011041350A2 Xenotropic mulv-related virus (xmrv) compositions and methods of use |
| 04/07/2011 | WO2011041003A2 Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| 04/07/2011 | WO2011040972A1 Anti-fibroblast activation protein antibodies and methods and uses thereof |
| 04/07/2011 | WO2011040811A1 Adjuvanted vaccine formulations |
| 04/07/2011 | WO2011040651A1 Therapeutic agent for atopic dermatitis |
| 04/07/2011 | WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 04/07/2011 | WO2011040565A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040527A1 TRANSGENIC BIRD CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, VIRUS, AND VACCINE |
| 04/07/2011 | WO2011040526A1 VIRUS CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, AND METHOD FOR PRODUCTION OF VACCINE |
| 04/07/2011 | WO2011040428A1 Anti-tumor agent and method for screening for same |
| 04/07/2011 | WO2011040133A1 Human serum amyloid-a3 antibody and use thereof |
| 04/07/2011 | WO2011039724A1 Antibodies that specifically bind to the epha2 receptor |
| 04/07/2011 | WO2011039639A2 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 04/07/2011 | WO2011039507A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/07/2011 | WO2011039180A2 Novel vaccine composition |
| 04/07/2011 | WO2011039096A1 Drug fusions and conjugates with extended half life |
| 04/07/2011 | WO2011038737A1 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof |
| 04/07/2011 | WO2011038701A1 Hepatitis b virus antigen formulation for cell stimulation followed by therapeutic immunization |
| 04/07/2011 | WO2011038700A1 Inhibitors of fam3b gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals |
| 04/07/2011 | WO2011038689A1 Novel human cytokine vstm1-v2 and use thereof |
| 04/07/2011 | WO2011038575A1 Novel antibody treatment |
| 04/07/2011 | WO2011038537A1 Methods and kits for the prediction, prevention and treatment of septicemia and septic shock |
| 04/07/2011 | WO2011038473A1 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines |
| 04/07/2011 | WO2011038467A1 Method of treatment of philadelphia chromosome positive leukaemia |
| 04/07/2011 | WO2011013097A3 Polymer particles and uses thereof |
| 04/07/2011 | WO2010151159A3 Virus-like particle vector as a polyvalent platform for intracellular delivery of high-molecular-weight therapeutic substances, method for generating a virus like particle vector and use of a virus-like particle vector and a pharmaceutical composition containing said virus-like particle vector |
| 04/07/2011 | WO2010132758A3 Ospc-based diagnostic test for lyme disease |
| 04/07/2011 | WO2010119343A3 Compositions for immunising against staphylococcus aerus |
| 04/07/2011 | US20110082287 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 04/07/2011 | US20110081657 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081417 Surgical compositions |
| 04/07/2011 | US20110081414 Method for Encapsulation of Orally Ingested Materials to Alter the Site of Digestion, Site of Action, or Stability |
| 04/07/2011 | US20110081409 Selective inhibitors of histone deacetylase |
| 04/07/2011 | US20110081408 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081407 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081406 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081383 Live attenuated leishmania vaccines |
| 04/07/2011 | US20110081382 Treatment and prevention of tuberculosis |
| 04/07/2011 | US20110081381 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110081380 Stabilizing Excipient for Inactivated Whole Virus Vaccine |
| 04/07/2011 | US20110081379 Purification method and method of producing vaccine |
| 04/07/2011 | US20110081378 Composition comprising iscom particles and live micro-organisms |
| 04/07/2011 | US20110081377 Aerosolized genetic vaccines and methods of use |
| 04/07/2011 | US20110081376 Method for using inactivated japanese encephalitis virus particles as adjuvant |
| 04/07/2011 | US20110081375 Chimeric adenoviral vectors |
| 04/07/2011 | US20110081374 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 04/07/2011 | US20110081373 Attenuating mutations in the influenza a virus nep(=ns2) protein |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081370 Methods and Compositions for Modulating Immune Tolerance |
| 04/07/2011 | US20110081369 Immune modulation with death receptor-induced apoptosis |
| 04/07/2011 | US20110081368 Protein vaccines against poxviruses |
| 04/07/2011 | US20110081367 Influenza sequences |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081365 Compounds and compositions as tlr activity modulators |
| 04/07/2011 | US20110081364 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 04/07/2011 | US20110081363 Compositions and methods for biological sample storage |
| 04/07/2011 | US20110081362 Treatment of cancer |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 04/07/2011 | US20110081358 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 04/07/2011 | US20110081357 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 04/07/2011 | US20110081356 Anti-cancer drug |
| 04/07/2011 | US20110081355 Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies |
| 04/07/2011 | US20110081354 Anti-ctla-4 antibodies with reduced blocking of binding of ctla-4 to b7 and uses thereof |
| 04/07/2011 | US20110081353 Antibody against the csf-1 r |
| 04/07/2011 | US20110081352 Immunogenic peptides and methods of use for treating and preventing cancer |
| 04/07/2011 | US20110081351 Antihuman baff antibody |
| 04/07/2011 | US20110081350 Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions |
| 04/07/2011 | US20110081349 Allergenic latex protein |
| 04/07/2011 | US20110081348 Fungal signalling and metabolic enzymes |
| 04/07/2011 | US20110081347 Antibodies with Altered Binding to FcRn and Methods of Using Same |
| 04/07/2011 | US20110081346 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/07/2011 | US20110081345 Single chain fc, methods of making and methods of treatment |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |